{
  "context": {
    "rules": [
      "Rule1: Provided that research was funded for virus strain Alpha, global collaboration is activated for the pandemic response.",
      "Rule2: Research was funded for virus strain Alpha, or research was funded for virus strain Beta.",
      "Rule3: Either the pathogen was isolated for virus strain Alpha, or global collaboration is activated for the pandemic response.",
      "Rule4: The pathogen was isolated for virus strain Beta, or it is not the case that the pathogen was isolated for virus strain Alpha.",
      "Rule5: If the modeling platform, pandemic simulator, was deployed, then the pathogen was not isolated for virus strain Beta.",
      "Rule6: Under the condition that fieldwork is conducted in the outbreak zone, a survey is conducted on the local population.",
      "Rule7: Fieldwork was conducted in the outbreak zone, or the modeling platform, pandemic simulator, was deployed.",
      "Rule8: Provided that a survey was conducted on the local population, interviews were conducted with healthcare workers.",
      "Rule9: Whenever interviews are conducted with healthcare workers, data is collected from patient samples.",
      "Rule10: Peer review was completed for the new assay, or the field test was completed for the new assay.",
      "Rule11: Under the condition that the field test was completed for the new assay, global collaboration is activated for the pandemic response.",
      "Rule12: A natural phenomenon, animal migration, was observed, or a natural phenomenon, a climate anomaly, was observed.",
      "Rule13: Under the condition that a natural phenomenon, a climate anomaly, was observed, global collaboration is activated for the pandemic response.",
      "Rule14: Either the transmission hypothesis of a zoonotic jump was confirmed, or, if a natural phenomenon, animal migration, was observed, then global collaboration is activated for the pandemic response.",
      "Rule15: If a vaccine candidate, the subunit vaccine, was identified, then the transmission hypothesis of human-to-human spread was confirmed.",
      "Rule16: Provided that a vaccine candidate, the mRNA vaccine, was identified, the transmission hypothesis of a zoonotic jump was not confirmed.",
      "Rule17: Whenever the lab is authorized at biosafety level 4, a containment breach occurs at the main facility.",
      "Rule18: The lab is authorized at biosafety level 4, or, if research was funded for virus strain Beta, then global collaboration is activated for the pandemic response.",
      "Rule19: If funding was secured from a public health agency, then, if neither a vaccine candidate, the subunit vaccine, was identified nor a vaccine candidate, the mRNA vaccine, was identified, a clinical trial, phase one, was not initiated.",
      "Rule20: Funding was secured from a public health agency, or funding was secured from a private foundation.",
      "Rule21: Under the condition that funding was secured from a private foundation, if it is not the case that either a vaccine candidate, the subunit vaccine, was identified or a vaccine candidate, the mRNA vaccine, was identified, then a clinical trial, phase one, was not initiated.",
      "Rule22: The data platform, the global dashboard, is operational, or, if global collaboration is not activated for the pandemic response, then all research projects are suspended.",
      "Rule23: If an algorithm, the machine learning model, was trained, then, if it is not the case that if it is not the case that either the data platform, the local portal, is operational or the data platform, the global dashboard, is not operational, then real-time tracking is enabled for the outbreak, then forecasting is not accurate for the outbreak trajectory.",
      "Rule24: An algorithm, the machine learning model, was trained, or an algorithm, the statistical model, was trained.",
      "Rule25: Whenever an algorithm, the statistical model, is trained, parameters are calibrated for the statistical model.",
      "Rule26: If parameters were calibrated for the statistical model, then, if it is not the case that if it is not the case that either the data platform, the local portal, is operational or the data platform, the global dashboard, is not operational, then real-time tracking is enabled for the outbreak, then forecasting is not accurate for the outbreak trajectory.",
      "Rule27: If manufacturing was scaled up for vaccine production, then a clinical trial, phase one, was not initiated.",
      "Rule28: Provided that the distribution network, the cold chain, was activated, manufacturing was scaled up for vaccine production.",
      "Rule29: If the supply chain for raw materials was secured, then, if regulatory approval was granted for emergency use, the distribution network, the cold chain, was activated.",
      "Rule30: The supply chain for raw materials was secured, or the supply chain for logistics partners was secured.",
      "Rule31: Whenever the supply chain for logistics partners is secured, the workforce, distribution personnel, is trained.",
      "Rule32: Provided that the workforce, distribution personnel, was trained, a monitoring system was deployed for the distribution network.",
      "Rule33: Under the condition that a monitoring system was deployed for the distribution network, then, if regulatory approval was granted for emergency use, the distribution network, the cold chain, was activated.",
      "Rule34: If an ethics committee was convened at the international level, then an ethics review was completed for the trial protocol.",
      "Rule35: An ethics committee was convened at the international level, or an ethics committee was convened at the national level.",
      "Rule36: Whenever an ethics committee is convened at the national level, community engagement is conducted at the trial sites.",
      "Rule37: If the main facility passed the safety audit, then a containment breach did not occur at the main facility.",
      "Rule38: The main facility passed the safety audit, or the remote lab passed the safety audit.",
      "Rule39: Under the condition that the disease mutated in virus strain Alpha, antiviral resistance was observed in the new variant.",
      "Rule40: If new research was initiated for variant analysis, then genomic sequencing was accelerated for variant analysis.",
      "Rule41: Whenever a protocol violation is reported at the remote lab, a containment breach does not occur at the main facility.",
      "Rule42: Provided that an equipment malfunction occurred at the remote lab, a protocol violation was reported at the remote lab.",
      "Rule43: Under the condition that it is not the case that if peer review was completed for the new assay, then the diagnostic skill of the new assay was validated, a revision was requested for the new assay.",
      "Rule44: Whenever it is not the case that if peer review was completed for the new assay, then the diagnostic skill of the new assay was validated, publication was not delayed for the new assay.",
      "Rule45: Provided that it is not the case that if a revision was requested for the new assay, then publication was delayed for the new assay, the journal rejected the new assay.",
      "Rule46: If it is not the case that if a revision was requested for the new assay, then publication was delayed for the new assay, then the journal did not reject the new assay.",
      "Rule47: Under the condition that neither a vaccine candidate, the subunit vaccine, was identified nor a vaccine candidate, the mRNA vaccine, was identified, a clinical trial, phase one, was initiated.",
      "Rule48: Whenever it is not the case that either a vaccine candidate, the subunit vaccine, was identified or a vaccine candidate, the mRNA vaccine, was identified, regulatory approval is granted for emergency use.",
      "Rule49: Under the condition that it is not the case that either the data platform, the local portal, is operational or the data platform, the global dashboard, is not operational, real-time tracking is not enabled for the outbreak.",
      "Rule50: If it is not the case that if community engagement was conducted at the trial sites, then, if neither a vaccine candidate, the subunit vaccine, was identified nor a vaccine candidate, the mRNA vaccine, was identified, a clinical trial, phase one, was not initiated, then the disease mutated in virus strain Alpha.",
      "Rule51: Provided that it is not the case that if antiviral resistance was observed in the new variant, then vaccine efficacy was reduced against the new variant, new research was initiated for variant analysis.",
      "Rule52: Under the condition that it is not the case that if the remote lab passed the safety audit, then an equipment malfunction occurred at the remote lab, an investigation was launched at the remote lab.",
      "Rule53: Whenever it is not the case that if it is not the case that either the data platform, the local portal, is operational or the data platform, the global dashboard, is not operational, then real-time tracking is enabled for the outbreak, forecasting is accurate for the outbreak trajectory.",
      "Rule54: Under the condition that global collaboration is not activated for the pandemic response, all research projects are not suspended."
    ],
    "facts": [
      "Fact1: Data was not collected from patient samples.",
      "Fact2: The diagnostic skill of the new assay was not validated.",
      "Fact3: The transmission hypothesis of human-to-human spread was not confirmed.",
      "Fact4: The data platform, the local portal, is not operational.",
      "Fact5: An ethics review was not completed for the trial protocol.",
      "Fact6: Vaccine efficacy was not reduced against the new variant.",
      "Fact7: Genomic sequencing was not accelerated for variant analysis.",
      "Fact8: An investigation was not launched at the remote lab."
    ]
  },
  "question": "Global collaboration was activated for the pandemic response."
}